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Background: Accurate diagnosis of malaria infections remains challenging, especially in the identification of
submicroscopic infections. New molecular diagnostic tools that are inexpensive, sensitive enough to detect
low-level infections and suitable in laboratory settings of resource-limited countries are required for malaria control
and elimination programmes. Here the diagnostic potential of a recently developed photo-induced electron transfer
fluorogenic primer (PET) real-time polymerase chain reaction (PCR) called PET-PCR was investigated. This study
aimed to (i) evaluate the use of this assay as a method for the detection of both Plasmodium falciparum and other
Plasmodium species infections in a developing country’s diagnostic laboratory; and, (ii) determine the assay’s
sensitivity and specificity compared to a nested 18S rRNA PCR.
Methods: Samples used in this study were obtained from a previous study conducted in the region of Iringa,
Tanzania. A total of 303 samples from eight health facilities in Tanzania were utilized for this evaluation. All samples
were screened using the multiplex PET-PCR assay designed to detect Plasmodium genus and P. falciparum initially
in laboratory in Tanzania and then repeated at a reference laboratory at the CDC in the USA. Microscopy data was
available for all the 303 samples. A subset of the samples were tested in a blinded fashion to find the sensitivity
and specificity of the PET-PCR compared to the nested 18S rRNA PCR.
Results: Compared to microscopy, the PET-PCR assay was 59% more sensitive in detecting P. falciparum infections.
The observed sensitivity and specificity were 100% (95% confidence interval (CI0.95) = 94-100%) and (CI0.95 = 96-100%),
respectively, for the PET-PCR assay when compared to nested 18S rRNA PCR. When compared to 18S rRNA PCR,
microscopy had a low sensitivity of 40% (CI0.95 = 23-61%) and specificity of 100% (CI0.95 = 96-100%). The PET-PCR results
performed in the field laboratory in Tanzania were in 100% concordance with the results obtained at the reference
laboratory in the USA.
Conclusion: The PET-PCR is a new molecular diagnostic tool with similar performance characteristics as commonly used PCR
methods that is less expensive, easy to use, and amiable to large scale-surveillance studies in developing country settings.
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Malaria is caused by protozoan parasites of the genus
Plasmodium that infect humans through the bite of an
infected female Anopheles mosquito. Plasmodium falcip-
arum, Plasmodium vivax, Plasmodium ovale, and Plas-
modium malariae, all lead to malaria in humans, with* Correspondence: NLucchi@cdc.gov
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stated.the first two species causing most malaria associated
mortality and morbidity. Although progress has been
made towards controlling malaria worldwide, it con-
tinues to be a major public health problem [1,2]. The
most recent report by the World Health Organization
(WHO) estimates that 216 million cases and 655,000
deaths occurred due to malaria in 2010 [2]. The report
further indicates that 106 countries are malaria endemic
and up to one-half of the worldwide population is at riskral Ltd. This is an Open Access article distributed under the terms of the Creative
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of malaria cases and 91% of malaria-related deaths [2].
Global malaria elimination and control programmes
currently rely mostly on two diagnostic tools: immuno-
chromatographic antigen-based rapid diagnostic tests
(RDTs) and microscopy, with RDTs pioneered in the
1980s and microscopy in the late 19th Century. Some of
the limitations of microscopy are that evaluating stained
blood smears is laborious and time consuming, it is dif-
ficult to standardize, and diagnosis of extremely low
density infections is very challenging and requires very
well-trained microscopists. Additionally, there is a two
to three-fold discrepancy in parasite quantification bet-
ween microscopists [3]. Yet microscopy is still the most
widely used method, with at least 165 million smears
reported to have been performed during 2010 [2], and
remains the reference standard for malaria diagnosis in
many malaria-endemic countries. The use of RDTs in
case management and control programmes seems effec-
tive. The target antigen in over 90% of RDTs is based on
detection of P. falciparum histidine-rich protein 2 (HRP-2)
antigen. RDTs that detect lactose dehydrogenase (LDH)
and aldolase are, in general, less specific in differentiating
different species of human malaria parasites although re-
cently, attempts have been made to improve the perfor-
mance of these tests. The evidence that a considerable
number of P. falciparum parasites in South America, have
a natural deletion of the HRP-2 gene [4] raises concerns
about the use of RDTs in some settings. Furthermore, new
data show that caution needs to be taken with the positive
predictive values of RDTs [5] and that many tests falls
below the desired 95% sensitivity/specificity target in poor
environmental conditions and in children under the age of
five years [5]. Nonetheless, RDTs are still a practical usable
diagnostic method in the management of febrile illness in
remote regions [6,7].
There is an urgent need for developing robust field
usable molecular tests with high level of sensitivity and
specificity for use in large-scale screening of samples from
malaria surveillance studies especially those that are
focused on malaria control and elimination. This need has
become particularly apparent in malaria containment pro-
jects that are focused on eliminating malaria in regions
where parasites resistant to artemisinin-based combi-
nation therapy (ACT) have evolved [8-10]. Advancements
in molecular technologies provide a continually evolving
and relatively low cost system for high-throughput scree-
ning of malaria in surveillance studies [11-13]. Molecular
methods are more reliable than traditional microscopy
and RDTs in accurately diagnosing the species of mal-
aria parasites and detecting low parasitaemia levels.
When considering the development of tools for large-
scale field application, it is desirable to consider cost,
robustness and ease of use. Recently, a novel real-timePCR assay that utilizes self-quenching primers for the
detection of Plasmodium spp., and P. falciparum was
developed [13]. Therefore, this PCR assay does not
require internal dual-labelled probes, which are usually
expensive, or use intercalating dyes, which are often non-
specific. The PET-PCR is an attractive molecular assay for
malaria detection, especially in surveillance studies in en-
demic countries where this methodology can be more
readily adopted than other probe-based real-time PCR
methods. The study herein aimed to evaluate the PET-
PCR assay for the detection of malaria parasites in a field
laboratory in Tanzania, and compare its performance to
microscopy and a widely used nested 18S rRNA PCR.
Methods
Study area and samples
Samples used in this study were obtained from a previous
study conducted in the Iringa region of Tanzania during
the years of 2010–2011 for assessing the accuracy of RDTs.
These were collected from the following eight health
facilities: (A) Tosamaganga, (B) Mlowa, (C) Kimande, (D)
Usokami, (E) Idodi, (F) Mafinga, (G) Kibao, and (H) Igo-
maa. The region and districts are shown in Figure 1 on the
2010 map of spatial distribution of P. falciparum malaria
endemicity and entomological inoculation rate (EIR) [14].
The two districts from which the samples were collected
have a P. falciparum prevalence (PfPR) and entomological
inoculation rate (PfEIR) of ≤5% and ≤1, respectively. A
blood smear and dried blood spot (DBS) samples were col-
lected as part of the original study. A subset of 303 DBS
samples, randomly selected from the eight health facilities,
was made available for use in this study.
Ethics statement
The parent study was reviewed by IHI and granted a na-
tional ethical permit from the Tanzanian National Insti-
tute for Medical Research (NIMR). It was determined by
CDC IRB to be a non-research activity with no require-
ment for consent from participants.
Microscopy
Both thick and thin smears were prepared per sample.
Depending on the health facility, the blood smears were
stained using 10% or 5% Giemsa solution buffered to
pH 7.2, and stained using a standard protocol. A blood
smear was considered negative when no parasite was de-
tectable after examining 100 high power fields. For posi-
tive smears, parasites were counted in reference to 200
white blood cells. Blood smears were first read by a dis-
trict laboratory technician in charge of laboratory ser-
vices in the rural districts where samples were collected.
The slides were then sent to a reference microscopy la-
boratory at IHI in Bagamoyo, Tanzania. Any discordant
reading between the district and reference microscopy
Figure 1 Regions in Tanzania screened for species-specific malaria infection using PET-PCR. Shown is the 2010 map of spatial distribution
of Plasmodium falciparum malaria endemicity and entomological inoculation rate (EIR) [14] in the region of Iringa where samples used in this
study were obtained. Samples were collected from eight health facilities as shown (A-H). Plasmodium falciparum prevalence (PfPR) and
entomological inoculation rate (PfEIR) for selected region are shown, 0% > PfPR ≤5% and 0.1 > PfEIR ≤1, respectively.
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nician from the Muhimbili University of Health and Al-
lied Sciences (MUHAS).
DNA extraction
DNA was isolated from DBS samples at IHI using the com-
mercially available QIAamp DNA Mini Kit (QIAGEN, Val-
encia, CA, USA). Genomic DNA was eluted with 100 μl of
elution buffer and stored at −20°C for use in PCR assays.
PET-PCR Assay
The PET-PCR assay was performed as previously de-
scribed with a few modifications [15]. Briefly, amplification
of the species (P. falciparum) and genus (Plasmodium)
DNA targets was performed in a 20 μl reaction containing
2X TaqMan Environmental Master Mix 2.0 (AppliedBioSystems), 125 nM of forward and reverse primers, ex-
cept the P. falciparum labelled primer whose concentra-
tion was 62.5 nM, and 2 μl of DNA template. The
reactions were performed under the following cycling pa-
rameters: initial hot-start at 95°C for 10 min, followed by
then 45 cycles of denaturation at 95°C for 10 sec, anneal-
ing at 60°C for 40 sec. The correct fluorescence channel
was selected for each fluorescently labelled primer set and
the cycle threshold (CT) values recorded at the end of the
annealing step. A cut-off CT value of 40 was used to indi-
cate a positive result. All samples were tested in duplicates
and repeated when necessary. The DNA stocks that were
used in Tanzania were also utilized in the USA reference
laboratory. The Stratagene Mx3000P real-time PCR sys-
tem was used to test all samples in both Tanzania and
the USA.
Table 1 Number of positive samples by health facilities as
detected by PET-PCR, nested 18S rRNA, and microscopy
Health facilities* A B C D E F G H Total
Total no of samples 51 33 36 31 46 23 59 24 303
PET-PCR positive 7 7 4 0 7 0 1 1 27
Nested 18S rRNA 7 7 4 0 7 0 1 1 27
Microscopy positive 1 3 4 0 3 0 0 0 11
*Health facilities: (A) Tosamaganga, (B) Mlowa, (C) Kimande, (D) Usokami, (E)
Idodi, (F) Mafinga, (G) Kibao, and (H) Igomaa. PET-PCR results shown are for
both Plasmodium falciparum and Plasmodium species.
Table 2 Sensitivity and specificity of the PET-PCR assay
and microscopy when compared to nested 18S rRNA PCR
Reference standard
Test result Nested 18S rRNA PCR
Multiplex PET PCR Present (+) Absent (−)
Test positive (+) 27 0 27 (18.75%)
Test negative (−) 0 117 117 (81.25%)
27 (18.75%) 117 (81.25%) 144 (100.00%)
95% confidence interval:
Lower limit Upper limit
Sensitivity 100.00% 94.04% 100.00%
Specificity 100.00% 96.10% 100.00%
PPV 100.00% 100.00% 100.00%
NPV 100.00% 100.00% 100.00%
Reference standard:
Test result: Nested 18S rRNA PCR
Microscopy Present (+) Absent (−)
Test positive (+) 11 0 11 (7.63%)
Test negative (−) 16 117 133 (92.36%)
27 (18.75%) 117 (81.25%) 144 (100.00%)
95% confidence interval:
Lower limit Upper limit
Sensitivity 40.70% 23.00% 61.00%
Specificity 100.00% 96.00% 100.00%
PPV 100.00% 67.90% 100.00%
NPV 87.70% 80.90% 92.80%
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Nested 18S rRNA PCR tests have been shown to be su-
perior in their sensitivity and specificity over microscopy
and are commonly used as reference tests for molecular
assays. Here the nested 18S rRNA PCR assay described
by Singh et al. was used as the reference standard [16].
Briefly, reactions were performed using 1 uL DNA tem-
plate in 20 μl total volume containing 1X buffer, 2.5 mM
MgCl2, 200 μM dNTPs, 200 nM primers, and 1.25 units
of Taq Polymerase (New England Biolabs, Ipswich, MA,
USA). The products were analysed for the appropriate
size on a 2% agarose gel. All nested 18S rRNA PCR was
performed at the Center for Disease Control and Pre-
vention (CDC) laboratory.
Data analysis
Data were analysed using the R software for statistical
computing [17]. For calculating sensitivity and specifi-
city, including the positive predictive value(s) (ppv) and
negative predictive value(s) (npv):
Sensitivity = # of true positives / (# of true positives + #
of false negatives)
Specificity = # of true negatives / (# of true negatives + #
of false positives)
Positive predictive value (ppv) = # of true positives/
(# of true positives + # of false positives)
Negative predictive value (npv) = # of true positives/
(# of true negatives + # of false negatives)
Results
Assessment of PET-PCR performance at a local laboratory
in Tanzania
Twenty-seven samples out of the 303 tested were found
to be positive for both P. falciparum and Plasmodium
spp. by PET-PCR when performed at the IHI laboratory
in Tanzania. The same samples were retested at the
CDC laboratory and 100% agreement was found be-
tween the PET-PCR results done at IHI and CDC.
Comparison of PET-PCR and microscopy
Microscopy detected 11 positive samples (3.63%) among
the 303 samples tested. These microscopy positive sam-
ples were confirmed to be positive by PET-PCR. In
addition, 16 microscopy-negative samples were found to
be positive for both P. falciparum and Plasmodium spp.
by PET-PCR (Table 1).
Sensitivity and specificity of PET-PCR and microscopy
To determine the sensitivity and specificity of the multi-
plex PET-PCR assay and microscopy, all 27 positive sam-
ples and a subset of 117 PET-PCR and microscopy
negative samples were tested using a nested 18S rRNA
PCR method as a reference test [16]. The samples were
randomly and in a blinded fashion selected with anaverage of 14 samples from each health facility. The data
showed 100% sensitivity (CI0.95 = 94-100%) and specificity
(CI0.95 = 96-100%) for the PET-PCR assay and 40% sensi-
tivity (CI0.95 = 23-61%) and 100% specificity (CI0.95 = 96-
100%) for microscopy (Table 2).
Discussion
Of the 303 samples from the eight health facilities, 8.9%
were found to be positive for P. falciparum by both PET-
PCR and nested 18S rRNA PCR. In contrast, only 3.6%
were positive by microscopy revealing a clear underestima-
tion of malaria infection when diagnosed by microscopy.
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microscopic infections. This is in agreement with previous
studies that reported the detection of a greater number of
submicroscopic infections by molecular methods [18-21].
Indeed, the PET-PCR assay compared favourably to the mo-
lecular reference standard, nested 18S rRNA PCR, with
100% agreement between both methods. However, PET-
PCR offers important advantages over standard nested PCR,
such as affordability, faster turnaround time, less chance for
DNA cross contamination due to lack of post PCR mani-
pulations, and is overall better suited for large scale scree-
ning. In addition, the assay was shown to be comparable to
the TaqMan-based real-time PCR method described by
Rougemont et al. [22] in which both the PET-PCR and
Rougemont assays showed a detection limit as low as 3.2
parasites/·L [15]. This detection limit is also comparable to
the reference standard nested 18S rRNA PCR where the de-
tection limit ranged between 0.64-3.2 parasites/·L [15]. Due
to the self-quenching nature of the PET primers this assay
does not require expensive probes, making it a relatively less
expensive method. The estimated average PET-PCR reagent
cost for this study was around US $2 per reaction. In
addition, the reconstituted PET primers and master mix can
be stored together at 4°C for up to a month or if the primers
are kept lyophilized can be stored until the end-user is ready
to use them. These practical advantages, along with the rela-
tively low cost, make PET-PCR a sustainable new method
for malaria detection for large scale screening of field sam-
ples. The multiplex PET-PCR assay was first tested in a local
diagnostic laboratory in Bagamoyo, Tanzania and then re-
peated at the CDC laboratory. A complete agreement of re-
sults was obtained between the two settings in performing
the PET-PCR assay, indicating that this assay can be suc-
cessfully utilized in a field laboratory in malaria-endemic
countries. In addition, most standard real-time PCR ma-
chines will be appropriate to carry out the assay.
Microscopy and RDTs still remain the most appropriate
methods for primary diagnosis of malaria in many malaria-
endemic countries. However, as the goal moves towards
malaria elimination, newer tools that are able to detect all
malaria cases, including low density infections not detec-
table by microscopy or RDTs, and that are applicable to
large-scale screening, are required. The PET-PCR assay
described herein provides such a tool as it has performance
characteristics similar to other commonly used molecular
methods and can be used in a developing country setting.
While this assay cannot yet be used in most primary health
facilities in many malaria-endemic regions, many reference
and research laboratories are already equipped for molecu-
lar testing such as PET-PCR.
Conclusion
The PET-PCR assay provides a relatively rapid and af-
fordable new molecular method for large-scale screeningof surveillance samples in support of malaria control and
elimination programmes in malaria-endemic countries.
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